Journal of Pharmacology and Experimental Therapeutics 2002-11-01

2'-NH(2)-MPTP [1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine] depletes serotonin and norepinephrine in rats: a comparison with 2'-CH(3)-MPTP [1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine].

Erica L Unger, Pascale Mazzola-Pomietto, Dennis L Murphy, Anne M Andrews

Index: J. Pharmacol. Exp. Ther. 303(2) , 527-33, (2002)

Full Text: HTML

Abstract

The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) analog, 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH(2)-MPTP), depletes brain serotonin and norepinephrine in mice without affecting striatal dopamine. The present study was conducted to determine whether 2'-NH(2)-MPTP would be similarly neurotoxic to rats. Four injections of 20 mg/kg 2'-NH(2)-MPTP caused 80 to 90% depletions in serotonin and norepinephrine in frontal cortex and hippocampus in rats 1 week post-treatment. A lower dose of 2'-NH(2)-MPTP (4 x 15 mg/kg) also produced large decrements in serotonin and norepinephrine levels and in serotonin transporter density measured 3 weeks after neurotoxin administration. Furthermore, this lower dose of 2'-NH(2)-MPTP altered functional serotonin neurotransmission as evidenced by a 2-fold potentiation of 1-(3-chlorophenyl)-piperazine.2HCl-induced hyperthermia, an index of serotonergic denervation supersensitivity. At both doses, 2'-NH(2)-MPTP was without effect on striatal dopamine. For comparison, additional rats were treated with a second 2'-substituted analog of MPTP, 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-CH(3)-MPTP), at 2 x 20 mg/kg. This dosing regimen causes substantial striatal dopamine depletion in mice. 2'-CH(3)-MPTP had no effect on brain levels of serotonin, norepinephrine, or dopamine in rats. Together, these results demonstrate that rats are sensitive to the toxic effects of 2'-NH(2)-MPTP but not to 2'-CH(3)-MPTP at doses known to cause neurotoxicity in mice. Moreover, this study clearly shows that 2'-NH(2)-MPTP can be utilized in rats as a tool to study the serotonergic and noradrenergic neurotransmitter systems.


Related Compounds

Related Articles:

The histochemical demonstration of MPTP oxidation in the postmortem human striatum.

1993-05-14

[Neurosci. Lett. 154(1-2) , 61-4, (1993)]

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) disrupts social memory/recognition processes in the male mouse.

1993-04-23

[Brain Res. 609(1-2) , 98-102, (1993)]

Imidazolium salt (DBZIM) reduces gliosis in mice treated with neurotoxicant 2'-CH(3) -MPTP.

2011-06-01

[CNS Neurosci. Ther. 17(3) , 148-57, (2011)]

Chronic CY 208-243 treatment of MPTP-monkeys causes regional changes of dopamine and GABAA receptors.

1993-11-26

[Neurosci. Lett. 163(1) , 31-5, (1993)]

Correlation between 1-methyl-4-phenylpyridinium ion (MPP+) levels, ascorbic acid oxidation and glutathione levels in the striatal synaptosomes of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated rat.

1993-10-29

[Neurosci. Lett. 161(2) , 121-3, (1993)]

More Articles...